FOCUS magazine showcases a selection of our original resources. You can use the educational content featured in FOCUS to identify and reduce barriers that prevent people from accessing the medicines they need.

Contributor
He Ako Hiringa
16 June 2022
60 minutes to Delve

Explore your prescribing further with EPiC Reflect CVD. This activity helps you to delve into your EPiC data, contemplate your prescribing, reflect on your current practice, and set goals and actions. Available as an editable PDF document, EPiC Reflect helps you to incorporate your learning into your everyday practice.

Contributor
He Ako Hiringa
9 June 2022
15 minutes to Read

Molnupiravir (Lagevrio) is an oral antiviral for treating patients with COVID-19 in the community.

Access criteria are the same as for nirmatrelvir/ritonavir (Paxlovid). Molnupiravir should only be used where nirmatrelvir/ritonavir is clinically inappropriate, as trial data suggest molnupiravir is much less effective. Read our article for details.

Contributor
He Ako Hiringa, reviewed by Eamon Duffy
20 May 2022
60 minutes to Delve

Explore your prescribing further with EPiC Reflect Annual Report. This activity helps you to delve into your EPiC data, contemplate your prescribing, reflect on your current practice, and set goals and actions. Available as an editable PDF document, EPiC Reflect helps you to incorporate your learning into your everyday practice.

Contributor
He Ako Hiringa
4 May 2022
60 minutes to Delve

Explore your prescribing further with EPiC Reflect Gout. This activity helps you to delve into your EPiC data, contemplate your prescribing, reflect on your current practice, and set goals and actions. Available as an editable PDF document, EPiC Reflect helps you to incorporate your learning into your everyday practice.

Contributor
He Ako Hiringa
20 April 2022
60 minutes to Delve

Explore your prescribing further with EPiC Reflect Diabetes. This activity helps you to delve into your EPiC data, contemplate your prescribing, reflect on your current practice, and set goals and actions. Available as an editable PDF document, EPiC Reflect helps you to incorporate your learning into your everyday practice.

Contributor
He Ako Hiringa
14 April 2022
8 minutes to Read + 7 minutes to Delve

Since 1 April 2022, the oral antiviral combination nirmatrelvir/ritonavir (Paxlovid) has been listed on the Pharmaceutical Schedule for treating patients with COVID-19 in the community. This resource for prescribers and dispensing pharmacists links to Pharmac's access criteria and to comprehensive drug interaction guidance.

Contributor
Eamon Duffy
31 March 2022